|
|
||||||||
Institute of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark
In this study, we investigate the state of T cell-mediated immunity in B cell-deficient (B-/-) mice infected with two strains of lymphocytic choriomeningitis virus known to differ markedly in their capacity to persist. In B-/- C57BL mice infected with the more persisting virus, virus-specific CD8+ T cells are initially generated that are qualitatively similar to those in wild-type mice. However, although cell numbers are well sustained over time, the capacity to produce cytokines is rapidly impaired. In similarly infected B-/- BALB/c mice, virus-specific CD8+ T cells are completely deleted, indicating that host genotype influences the severity of the T cell defect. In B-/- C57BL mice infected with the less persisting virus, CD8+ T cell dysfunction was not as pronounced, although it was clearly present. Most importantly, the appearance of dysfunctional CD8+ T cells clearly precedes recrudescence of detectable virus, indicating that the T cell defect is not simply a secondary event due to virus buildup resulting from the failure of B-/- mice to produce neutralizing Abs. In contrast with CD8+ T cells, which initially respond almost as in wild-type mice, the priming of virus-specific CD4+ T cells was markedly impaired in B-/- mice infected with either virus strain. Thus, our results indicate that B cells play an important role in antiviral immunity not only as Ab producers, but also in promoting an optimal and sustained T cell response. The T cell defects are likely to contribute to the chronic course of viral infection in B-/- mice.
This article has been cited by other articles:
![]() |
M. Grujic, P. J. Holst, J. P. Christensen, and A. R. Thomsen Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice J. Gen. Virol., February 1, 2009; 90(2): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Holst, M. R. Sorensen, C. M. Mandrup Jensen, C. Orskov, A. R. Thomsen, and J. P. Christensen MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines J. Immunol., March 1, 2008; 180(5): 3339 - 3346. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Ashour and T. M. Seif The role of B cells in the induction of peripheral T cell tolerance J. Leukoc. Biol., November 1, 2007; 82(5): 1033 - 1039. [Full Text] [PDF] |
||||
![]() |
M. K. Mann, K. Maresz, L. P. Shriver, Y. Tan, and B. N. Dittel B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis J. Immunol., March 15, 2007; 178(6): 3447 - 3456. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Lund, M. Hollifield, K. Schuer, J. L. Lines, T. D. Randall, and B. A. Garvy B Cells Are Required for Generation of Protective Effector and Memory CD4 Cells in Response to Pneumocystis Lung Infection J. Immunol., May 15, 2006; 176(10): 6147 - 6154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ugleholdt, M.-L. H. Poulsen, P. J. Holst, J.-C. Irminger, C. Orskov, J. Pedersen, M. M. Rosenkilde, X. Zhu, D. F. Steiner, and J. J. Holst Prohormone Convertase 1/3 Is Essential for Processing of the Glucose-dependent Insulinotropic Polypeptide Precursor J. Biol. Chem., April 21, 2006; 281(16): 11050 - 11057. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Casadevall and L.-a. Pirofski New Concepts in Antibody-Mediated Immunity Infect. Immun., November 1, 2004; 72(11): 6191 - 6196. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |